Genfleet (HKG: 02595)

Shanghai, China · Founded 2017 · Publicly Held

GenFleet Therapeutics (Shanghai) Inc is a biopharmaceutical company focused on developing novel treatment options in the fields of oncology, covering different lines of treatments of multiple solid… Genfleet (HKG: 02595) is based in Shanghai, China and was founded in 2017. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $800 million (Sep 2025). It has raised $205 million.

Last price · $/share
—
Implied valuation
$799.7M
Total raised
$204.8M
Last round
—

Who backs Genfleet (HKG: 02595)?

10 investors
InvestorType
OrbiMedGrowth equity
Suzhou Guofa Venture CapitalOther
CITIC CapitalAsset manager
Lake Bleu CapitalHedge fund
China Universal Asset ManagementAsset manager
Trumed Investment ManagementHedge fund
Guoxin Sichuang Investment—
HM Venture Partners—
Huimei Technology—
UBS Asset Management (Europe)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Genfleet (HKG: 02595) investors

10 investors are on record for Genfleet (HKG: 02595), including OrbiMed, Suzhou Guofa Venture Capital, CITIC Capital and Lake Bleu Capital. By type, the record holds 2 hedge funds, 2 asset managers and 1 growth equity firm.

Free account
More of Genfleet (HKG: 02595) with a free account
  • ·Watch Genfleet (HKG: 02595): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Genfleet (HKG: 02595). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View